Search

Your search keyword '"Goldman, A"' showing total 545 results

Search Constraints

Start Over You searched for: Author "Goldman, A" Remove constraint Author: "Goldman, A" Journal the lancet Remove constraint Journal: the lancet
545 results on '"Goldman, A"'

Search Results

1. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.

2. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

3. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

4. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial

8. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

9. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

10. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial

11. Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London

13. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

14. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

16. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

17. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

18. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN)

22. The UK needs a sustainable strategy for COVID-19

23. Scientific consensus on the COVID-19 pandemic: we need to act now

24. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

25. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

26. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease

29. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

35. European experience of bone-marrow transplantation for severe combined immunodeficiency

37. Assessment of priority for coronary revascularisation procedures

38. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Catalog

Books, media, physical & digital resources